Udg Healthcare PLC (LON:UDG) had its price objective lifted by stock analysts at Berenberg Bank from GBX 700 ($8.75) to GBX 720 ($9.00) in a research report issued to clients and investors on Friday. The brokerage currently has a “buy” rating on the stock. Berenberg Bank’s target price indicates a potential upside of 12.15% from the company’s current price.

UDG has been the topic of several other research reports. Numis Securities Ltd reiterated an “add” rating and issued a GBX 730 ($9.12) target price on shares of Udg Healthcare PLC in a research report on Monday, October 24th. Jefferies Group lifted their target price on shares of Udg Healthcare PLC from GBX 680 ($8.50) to GBX 720 ($9.00) and gave the company a “buy” rating in a research report on Friday, September 30th. Davy Research restated an “outperform” rating on shares of Udg Healthcare PLC in a research report on Monday, October 24th. Liberum Capital assumed coverage on shares of Udg Healthcare PLC in a research report on Thursday, October 27th. They set a “buy” rating and a GBX 750 ($9.37) price target on the stock. Finally, Stifel Nicolaus restated a “hold” rating and set a GBX 620 ($7.75) price target on shares of Udg Healthcare PLC in a research report on Wednesday, September 28th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of GBX 692.50 ($8.65).

Analyst Recommendations for Udg Healthcare PLC (LON:UDG)

Udg Healthcare PLC (LON:UDG) opened at 642.00 on Friday. Udg Healthcare PLC has a 12 month low of GBX 491.30 and a 12 month high of GBX 692.50. The stock’s 50 day moving average is GBX 651.28 and its 200-day moving average is GBX 613.71. The stock’s market capitalization is GBX 1.58 billion.

In other Udg Healthcare PLC news, insider Chris Corbin sold 90,849 shares of the business’s stock in a transaction dated Monday, September 26th. The shares were sold at an average price of GBX 634 ($7.92), for a total value of £575,982.66 ($719,618.52).

About Udg Healthcare PLC

UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.

Receive News & Stock Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related stocks with our FREE daily email newsletter.